Utah Life Sciences News & Events

March 20, 2023

January 25, 2025

This week’s newsletter included:

Acadia Pharmaceuticals Announces U.S. FDA Approval of Daybue™ (trofinetide) for the Treatment of Rett Syndrome in Adult and Pediatric Patients Two Years of Age and Older
Utah Company, KUDA Therapeutics, Awarded $2 Million Grant for Cancer Research
BD Receives FDA 510(k) Clearance for First-of-Its-Kind High-Throughput Diagnostic Test for Infectious Vaginitis
Women Tech Council Recognizes Four BioUtah Members
100 Companies Championing Women Nomination Application